These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. High BRE expression in pediatric MLL-rearranged AML is associated with favorable outcome. Balgobind BV; Zwaan CM; Reinhardt D; Arentsen-Peters TJ; Hollink IH; de Haas V; Kaspers GJ; de Bont ES; Baruchel A; Stary J; Meyer C; Marschalek R; Creutzig U; den Boer ML; Pieters R; van den Heuvel-Eibrink MM Leukemia; 2010 Dec; 24(12):2048-55. PubMed ID: 20861917 [TBL] [Abstract][Full Text] [Related]
7. Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint. Archimbaud E; Charrin C; Magaud JP; Campos L; Thomas X; Fière D; Rimokh R Leukemia; 1998 Jan; 12(1):25-33. PubMed ID: 9436917 [TBL] [Abstract][Full Text] [Related]
9. AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases. Schoch C; Schnittger S; Klaus M; Kern W; Hiddemann W; Haferlach T Blood; 2003 Oct; 102(7):2395-402. PubMed ID: 12805060 [TBL] [Abstract][Full Text] [Related]
10. MLL gene rearrangement, cytogenetic 11q23 abnormalities, and expression of the NG2 molecule in infant acute myeloid leukemia. Hilden JM; Smith FO; Frestedt JL; McGlennen R; Howells WB; Sorensen PH; Arthur DC; Woods WG; Buckley J; Bernstein ID; Kersey JH Blood; 1997 May; 89(10):3801-5. PubMed ID: 9160687 [TBL] [Abstract][Full Text] [Related]
11. [Clinical and experimental studies of childhood acute myeloid leukemia with 11q23/MLL rearrangements]. He YX; Xue YQ; Wang HY; Shao XJ; Pan JL; Xu J; Yang NC; Ji ZH; Huang YP; Hu SY Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):677-82. PubMed ID: 23225048 [TBL] [Abstract][Full Text] [Related]
12. MLL-rearranged acute myeloid leukemia: Influence of the genetic partner in allo-HSCT response and prognostic factor of MLL 3' region mRNA expression. Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Carrillo E; Sánchez J; Pérez-López O; Pérez de Soto I; González Campos J; Prats-Martín C; Bernal R; Vargas MT Eur J Haematol; 2018 May; 100(5):436-443. PubMed ID: 29384595 [TBL] [Abstract][Full Text] [Related]
13. Frequency and clinical significance of the MLL gene rearrangements in infant acute leukemia. Taki T; Ida K; Bessho F; Hanada R; Kikuchi A; Yamamoto K; Sako M; Tsuchida M; Seto M; Ueda R; Hayashi Y Leukemia; 1996 Aug; 10(8):1303-7. PubMed ID: 8709635 [TBL] [Abstract][Full Text] [Related]
14. Mutational landscape and clinical outcome of pediatric acute myeloid leukemia with 11q23/KMT2A rearrangements. Yuen KY; Liu Y; Zhou YZ; Wang Y; Zhou DH; Fang JP; Xu LH Cancer Med; 2023 Jan; 12(2):1418-1430. PubMed ID: 35833755 [TBL] [Abstract][Full Text] [Related]
15. Incidence and characterization of MLL gene (11q23) rearrangements in acute myeloid leukemia M1 and M5. Poirel H; Rack K; Delabesse E; Radford-Weiss I; Troussard X; Debert C; Leboeuf D; Bastard C; Picard F; Veil-Buzyn A; Flandrin G; Bernard O; Macintyre E Blood; 1996 Mar; 87(6):2496-505. PubMed ID: 8630416 [TBL] [Abstract][Full Text] [Related]
16. The heterogeneity of pediatric MLL-rearranged acute myeloid leukemia. Balgobind BV; Zwaan CM; Pieters R; Van den Heuvel-Eibrink MM Leukemia; 2011 Aug; 25(8):1239-48. PubMed ID: 21566656 [TBL] [Abstract][Full Text] [Related]
17. Incidence of MLL rearrangement in acute myeloid leukemia, and a CALM-AF10 fusion in M4 type acute myeloblastic leukemia. Abdou SM; Jadayel DM; Min T; Swansbury GJ; Dainton MG; Jafer O; Powles RL; Catovsky D Leuk Lymphoma; 2002 Jan; 43(1):89-95. PubMed ID: 11911106 [TBL] [Abstract][Full Text] [Related]
18. Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML. Schnittger S; Kinkelin U; Schoch C; Heinecke A; Haase D; Haferlach T; Büchner T; Wörmann B; Hiddemann W; Griesinger F Leukemia; 2000 May; 14(5):796-804. PubMed ID: 10803509 [TBL] [Abstract][Full Text] [Related]
19. AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic features. Haferlach T; Kohlmann A; Klein HU; Ruckert C; Dugas M; Williams PM; Kern W; Schnittger S; Bacher U; Löffler H; Haferlach C Leukemia; 2009 May; 23(5):934-43. PubMed ID: 19194466 [TBL] [Abstract][Full Text] [Related]
20. Fusion partner-specific mutation profiles and KRAS mutations as adverse prognostic factors in MLL-rearranged AML. Matsuo H; Yoshida K; Nakatani K; Harata Y; Higashitani M; Ito Y; Kamikubo Y; Shiozawa Y; Shiraishi Y; Chiba K; Tanaka H; Okada A; Nannya Y; Takeda J; Ueno H; Kiyokawa N; Tomizawa D; Taga T; Tawa A; Miyano S; Meggendorfer M; Haferlach C; Ogawa S; Adachi S Blood Adv; 2020 Oct; 4(19):4623-4631. PubMed ID: 32991719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]